Award details

Novel targets for vaccine development and immunotherapy to combat Staphylococcus aureus and other pathogens

ReferenceBB/D525748/1
Principal Investigator / Supervisor Professor Simon J. Foster
Co-Investigators /
Co-Supervisors
Institution University of Sheffield
DepartmentMolecular Biology and Biotechnology
Funding typeResearch
Value (£) 59,703
StatusCompleted
TypeResearch Grant
Start date 01/04/2006
End date 31/03/2007
Duration12 months

Abstract

Antibiotic resistant, pathogenic bacteria are a constant and increasing threat. An important alternative to antibiotics is disease prevention by vaccination and the use of therapeutic antibodies. The project will develop a new class of vaccine/antibody targets against the superbug Staphylococcus aureus and other infectious microbes. The targets are those which are essential for the life of the cell and so the bacterium cannot do without them. Our BBSRC funded work has identified suitable novel targets in S. aureus and has shown them to be accessible to the immune system. A patent has been filed by the University of Sheffield to protect this finding. For further exploitation and commercialisation the essential components need to be produced and their potential as vaccine constituents examined. Concomitant with scientific advances a commercial structure will be established to allow the full potential of the area to be realised.

Summary

unavailable
Committee Closed Committee - Plant & Microbial Sciences (PMS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative Follow-On Fund (FOF) [2004-2015]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file